A MULTICENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF LACOSAMIDE AS ADJUNCTIVE THERAPY IN SUBJECTS WITH EPILEPSY >1 MONTH TO <4 YEARS OF AGE WITH PARTIAL-ONSET SEIZURES
Clinical Trial Grant
Administered By
Pediatrics, Neurology
Awarded By
UCB Biosciences Inc.
Start Date
December 27, 2019
End Date
April 20, 2021
Administered By
Pediatrics, Neurology
Awarded By
UCB Biosciences Inc.
Start Date
December 27, 2019
End Date
April 20, 2021